EGFR and interstitial lung disease: suggested that the overall incidence of EGFR TKI pneumonitis was 1.12% in patients without prior exposure to EGFR TKI, and 1.13% in retreatment group, but interstitial lung disease or pneumonitis seems to be particularly common in Japanese patients (25).